Literature DB >> 31345427

Does Socioeconomic Status Influence the Risk of Subclinical Atherosclerosis?: A Mediation Model.

Lidia Redondo-Bravo1, Juan Miguel Fernández-Alvira2, Juan Górriz3, José María Mendiguren4, Javier Sanz5, Leticia Fernández-Friera6, José Manuel García-Ruiz7, Antonio Fernández-Ortiz8, Borja Ibáñez9, Héctor Bueno10, Valentín Fuster11.   

Abstract

BACKGROUND: Socioeconomic status (SES)-education, income level, and occupation-is associated with cardiovascular risk.
OBJECTIVES: This study aimed to investigate the association between SES and subclinical atherosclerosis and the potential mechanisms involved.
METHODS: SES, lifestyle habits (smoking, dietary patterns, physical activity, and hours of sleep), traditional risk factors, and subclinical atherosclerosis extent were prospectively assessed in 4,025 individuals aged 40 to 54 years without known cardiovascular disease enrolled in the PESA (Progression of Early Subclinical Atherosclerosis) study. After factors associated with atherosclerosis were identified, a multiple mediation model was created to quantify the effect of SES on subclinical atherosclerosis as explained by lifestyle behaviors.
RESULTS: Although education level was significantly associated with the presence of atherosclerosis, no differences were found according to income level in this population. Participants with lower education presented with a higher risk of generalized atherosclerosis than those with higher education (odds ratio: 1.46; 95% confidence interval: 1.15 to 1.85; p = 0.002). Lifestyle behaviors associated with both education level and atherosclerosis extent were: smoking status, number of cigarettes/day, and dietary pattern, which explained 70.5% of the effect of SES on atherosclerosis. Of these, tobacco habit (smoking status 35% and number of cigarettes/day 32%) accounted for most of the explained differences between groups, whereas dietary pattern did not remain a significant mediator in the multiple mediation model.
CONCLUSIONS: Despite the relative economic homogeneity of the cohort, lower education level is associated with increased subclinical atherosclerosis, mainly mediated by the higher and more frequent tobacco consumption. Smoking cessation programs are still needed, particularly in populations with lower education level.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atherosclerosis; education; mediation model; smoking; socioeconomic status

Mesh:

Year:  2019        PMID: 31345427     DOI: 10.1016/j.jacc.2019.05.042

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  5 in total

1.  Associations among circulating sphingolipids, β-cell function, and risk of developing type 2 diabetes: A population-based cohort study in China.

Authors:  Huan Yun; Liang Sun; Qingqing Wu; Geng Zong; Qibin Qi; Huaixing Li; He Zheng; Rong Zeng; Liming Liang; Xu Lin
Journal:  PLoS Med       Date:  2020-12-09       Impact factor: 11.069

2.  Proteinuria is independently associated with carotid atherosclerosis: a multicentric study.

Authors:  Wencai Jiang; Meixiang Chen; Jianyu Huang; Yu Shang; Changyu Qin; Zheng Ruan; Shuang Li; Ruixin Wang; Pengfei Li; Yuekang Huang; Jianxiong Liu; Lin Xu
Journal:  BMC Cardiovasc Disord       Date:  2021-11-19       Impact factor: 2.298

3.  Reply: Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis.

Authors:  Jihyun An; Ju Hyun Shim
Journal:  Clin Mol Hepatol       Date:  2022-01-18

4.  Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis.

Authors:  Yi-Chun Huang; Chih-Wei Chen; James Chun-Chung Wei
Journal:  Clin Mol Hepatol       Date:  2022-01-04

5.  The role of traditional risk factors in explaining the social disparities in cardiovascular death: The national health and Nutrition Examination Survey III (NHANES III).

Authors:  Wei Zhang; Muhammad Imtiaz Ahmad; Elsayed Z Soliman
Journal:  Am J Prev Cardiol       Date:  2020-10-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.